In this line, our in silico findings are supported by in vitro data reported by Khan et al. (2023) [60], where saffron treatment exerts antitumor effects in prostate cancer cell lines through the impairment of DNMT protein expression. The gene discussed is DNMT1; the disease is prostate carcinoma.